Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. Aripiprazole is a quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors.
Shi, Hang; Babinski, David J.; Ritter, Tobias. Modular C-H Functionalization Cascade of Aryl Iodides. Journal of the American Chemical Society. Volume 137. Issue 11. Pages 3775-3778. 2015.
Bonacorsi, Samuel J., Jr.; Waller, Stephen C.; Rinehart, J. Kent. Synthesis of multi-labeled [14C]aripiprazole. Journal of Labelled Compounds & Radiopharmaceuticals. Department of Chemical Synthesis The Bristol-Myers Squibb Pharmaceutical Research Institute. Volume 49. Issue 1. Pages 1-9. 2006.
Pai, Nandini R.; Dubhashi, Deepnandan S.; Pusalkar, Deeptanshu. Substituted 3,4-dihydro-1H-quinolin-2-one derivatives as potential antidepressant, sedative and antiparkinson agents. International Journal of Pharmaceutical Sciences Review and Research. Department of Organic Chemistry. D.G. Ruparel College. Volume 5. Issue 2. Pages 124-131. 2010.
Kowalski, Piotr; Jaskowska, Jolanta. An Efficient Synthesis of Aripiprazole, Buspirone and NAN-190 by the Reductive Alkylation of Amines Procedure. Archiv der Pharmazie (Weinheim, Germany). Institute of Organic Chemistry and Technology, Cracow University of Technology. Volume 345. Issue 1. Pages 81-85. Journal. 2012.
Yang, Li; Shi, Lijun; Xing, Qi; Huang, Kuo-Wei; Xia, Chungu; Li, Fuwei. Enabling CO Insertion into o-Nitrostyrenes beyond Reduction for Selective Access to Indolin-2-one and Dihydroquinolin-2-one Derivatives. ACS Catalysis. State Key Laboratory for Oxo Synthesis and Selective Oxidation, Suzhou Research Institute of LICP, Lanzhou Institute of Chemical Physics (LICP). Chinese Academy of Sciences. Volume 8. Issue 11. Pages 10340-10348. 2018.
Zhang, Zhaozhen; Zhu, Lihui; Pang, Wen; Zhu, Yidong; Hou, Zijie. Synthesis of aripiprazole. Zhongguo Yiyao Gongye Zazhi. Qilu Pharmaceutical Co., Ltd. Volume 40. Issue 1. Pages 6-8. 2009.
Liu, Xiu-jie; Wang, Ti-ti; Zhong, Yong-liang; Wang, Xiao. Synthesis of antipsychotic aripiprazole. Shenyang Yaoke Daxue Xuebao. The College of Chemistry and Chemical Engineering, Tianjin University of Technology. Volume 30. Issue 4. Pages 253-255. 2013.
Kollapudi, Chandra Babu; Gutta, Madhusudhan; Reguri, Buchi Reddy. Green methodologies in organic synthesis: microwave-assisted study on carbostyril derivatives under phase transfer catalysis. Heterocyclic Letters. Centre for Pharmaceutical Sciences, JNT University. Volume 5. Issue 2. Pages 213-221. 2015.
Czarnik, Anthony W. Deuterium-enriched aripiprazole for treatment of schizophrenia. Assignee Protia, LLC. 2008.
Du, Xiaochun; Qin, Xinrong; Cai, Fubo; Xu, Guanbing; Li, Wen. A process for preparing aripiprazole and its intermediates. Assignee Chengdu Kanghong Pharmaceutical Group Co., Ltd.2009.
